Large-scale testing (Phase 3)Study completedNCT03104413
What this trial is testing
Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Who this might be right for
Crohn's Disease
AbbVie 618